71 related articles for article (PubMed ID: 7967501)
1. Mechanisms of tumor-induced osteolysis.
Teitelbaum SL; Ross FP
Lab Invest; 1994 Oct; 71(4):453-5. PubMed ID: 7967501
[No Abstract] [Full Text] [Related]
2. Osteoclasts are required for bone tumors to grow and destroy bone.
Clohisy DR; Ramnaraine ML
J Orthop Res; 1998 Nov; 16(6):660-6. PubMed ID: 9877389
[TBL] [Abstract][Full Text] [Related]
3. Tumor osteolysis in osteopetrotic mice.
Clohisy DR; Ogilvie CM; Ramnaraine ML
J Orthop Res; 1995 Nov; 13(6):892-7. PubMed ID: 8544026
[TBL] [Abstract][Full Text] [Related]
4. [[From metastatic osteolysis a painful message: beginning to understand with osteoprotegerin?].
Bénard J
Bull Cancer; 2000 Sep; 87(9):623-4. PubMed ID: 11184451
[No Abstract] [Full Text] [Related]
5. Bone metastases studied by experimental models.
Galasko CS
Schweiz Med Wochenschr; 1981 Dec; 111(49):1862-8. PubMed ID: 7330640
[No Abstract] [Full Text] [Related]
6. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa S; Kitazawa R
J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
[TBL] [Abstract][Full Text] [Related]
7. [What's new in fundamental research: osteolysis and bone tumor].
Gouin F
Rev Chir Orthop Reparatrice Appar Mot; 2007 Jun; 93(4 Suppl):2S52-4. PubMed ID: 17646829
[TBL] [Abstract][Full Text] [Related]
8. Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.
Sevcik MA; Luger NM; Mach DB; Sabino MA; Peters CM; Ghilardi JR; Schwei MJ; Röhrich H; De Felipe C; Kuskowski MA; Mantyh PW
Pain; 2004 Sep; 111(1-2):169-80. PubMed ID: 15327821
[TBL] [Abstract][Full Text] [Related]
9. Osteolysis and cancer.
Goltzman D
J Clin Invest; 2001 May; 107(10):1219-20. PubMed ID: 11375409
[No Abstract] [Full Text] [Related]
10. [Cervical osteolysis. Initial manifestation of embryonal rhabdomyosarcoma].
Bléry M; Furno P; Chagnon S; Hammouda H
J Radiol; 1983 Jan; 64(1):61-4. PubMed ID: 6854530
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
12. Osteolytic metastases.
Lancet; 1976 Nov; 2(7994):1063-4. PubMed ID: 62905
[No Abstract] [Full Text] [Related]
13. Myeloma and bone disease: "the dangerous tango".
Epstein J; Walker R
Clin Adv Hematol Oncol; 2006 Apr; 4(4):300-6. PubMed ID: 16728940
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
15. Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice.
Clohisy DR; O' Keefe PF; Ramnaraine ML
J Orthop Res; 2001 Jul; 19(4):554-8. PubMed ID: 11518261
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis.
Morony S; Capparelli C; Sarosi I; Lacey DL; Dunstan CR; Kostenuik PJ
Cancer Res; 2001 Jun; 61(11):4432-6. PubMed ID: 11389072
[TBL] [Abstract][Full Text] [Related]
17. [Morphology of bone tumors. 1. Review and problems of osteolysis].
Haferkamp O
Aktuelle Probl Chir Orthop; 1977; 5():26-8. PubMed ID: 22265
[No Abstract] [Full Text] [Related]
18. Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells.
Takita M; Inada M; Maruyama T; Miyaura C
FEBS Lett; 2007 Feb; 581(3):565-71. PubMed ID: 17254571
[TBL] [Abstract][Full Text] [Related]
19. [Physiopathology of tumor-induced osteolysis].
Gouin F; Moreau A; Guicheux J; Passuti N; Heymann D
Rev Chir Orthop Reparatrice Appar Mot; 1999 Mar; 85(1):58-68. PubMed ID: 10327468
[TBL] [Abstract][Full Text] [Related]
20. Future treatment of bone metastases.
Lipton A
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6305s-6308s. PubMed ID: 17062719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
